Galera Therapeutics

Galera Therapeutics is an American clinical stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. The company was founded in 2012 and is headquartered in Malvern, Pennsylvania.
Galera Therapeutics stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Galera Therapeutics balance sheet

Report period2017 2018 2019 2020 2021
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Galera Therapeutics cash flows

Report period2017 2018 2019 2020 2021
End date of the reporting period
Sales
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Galera Therapeutics multipliers

Report period2017 2018 2019 2020 2021
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Galera Therapeutics profitability

Report period2017 2018 2019 2020 2021
ROA
ROE
ROS
Galera Therapeutics assets
Galera Therapeutics cash flows

Galera Therapeutics dividend policy

The company doesn't provide dividend

Galera Therapeutics shares

TickerNameTypeNominal valueISINPrice
GRTX:USGalera TherapeuticsCommon share-US36338D1081$0.049
Galera Therapeutics news
16.05.2022
Galera Therapeutics' GAAP loss for 3 months of 2022 was $15.443 million, down 17.5% from $18.715 million in the previous year.
Source: investors.galeratx.com pictogram investors.galeratx.com
Pictogram next
10.03.2022
Galera Therapeutics' GAAP loss for 2021 was $80.534 million, up 8.5 percent from $74.218 million the previous year.
Source: investors.galeratx.com pictogram investors.galeratx.com
Pictogram next
10.11.2021
Galera Therapeutics' GAAP loss for 9M 2021 was $63.727 million, up 17.7% from $54.152 million in the prior year.
Source: investors.galeratx.com pictogram investors.galeratx.com
Pictogram next
10.08.2021
Galera Therapeutics' GAAP loss for 6M 2021 was $41.101 million, up 10.9% from $37.074 million in the prior year.
Source: investors.galeratx.com pictogram investors.galeratx.com
Pictogram next
All Galera Therapeutics news
General information
Company nameGalera Therapeutics
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address2 West Liberty Blvd Suite 110 Malvern, PA 19355 United States
Mailing address2 West Liberty Blvd Suite 110 Malvern, PA 19355 United States
Websiteinvestors.galeratx.com
Information disclosurewww.sec.gov